Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients-Reference-Cited by-同舟云学术

Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients

Published:2021-08-06 Issue:6 Volume:25 Page:735-755
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Hirata Thiago Dominguez Crespo^ORCID,Dagli-Hernandez Carolina^ORCID,Genvigir Fabiana Dalla Vecchia^ORCID,Lauschke Volker Martin^ORCID,Zhou Yitian^ORCID,Hirata Mario Hiroyuki^ORCID,Hirata Rosario Dominguez Crespo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40291-021-00549-z.pdf

Reference129 articles.

1. Terrier J, Daali Y, Fontana P, Csajka C, Reny JL. Towards personalized antithrombotic treatments: focus on P2Y12 inhibitors and direct oral anticoagulants. Clin Pharmacokinet. 2019;58(12):1517–32. https://doi.org/10.1007/s40262-019-00792-y.

2. Lucà F, Giubilato S, Fusco SAD, Leone A, Poli S, Rao CM, Iorio A, Gelsomino S, Gabrielli D, Colivicchi F, De Luca L, Gulizia MM. The combination of oral anticoagulant and antiplatelet therapies: stay one step ahead. J Cardiovasc Pharmacol Ther. 2020;25(5):391–8. https://doi.org/10.1177/1074248420923528.

3. Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Shay CM, Spartano NL, Stokes A, Tirschwell DL, VanWagner LB, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–596. https://doi.org/10.1161/CIR.0000000000000757.

4. Maier CL, Duncan A, Hill CE. Pharmacogenetics in oral antithrombotic therapy. Clin Lab Med. 2016;36(3):461–72. https://doi.org/10.1016/j.cll.2016.05.002.

5. Storelli F, Daali Y, Desmeules J, Reny JL, Fontana P. Pharmacogenomics of oral antithrombotic drugs. Curr Pharm Des. 2016;22(13):1933–49. https://doi.org/10.2174/1381612822666151208122845.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Chinese patient with cardiogenic stroke and warfarin resistance: A case report;2024-04-09

2. Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure;Heliyon;2024-04

3. De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis;BMJ Evidence-Based Medicine;2024-01-19

4. Influence of IL-β, IL-1RN, and TNF-α variants on the risk of acetylsalicylic acid-induced upper gastrointestinal bleeding: a case-control study;einstein (São Paulo);2024

5. Genetic Variants of CYP4F2 Associated with Ischemic Stroke Susceptibility in the Han Population from Southern China;Pharmacogenomics and Personalized Medicine;2023-06